Back

Impact of troponin type and timing on the detection of periprocedural myocardial infarction and injury in the alpheus randomized trial

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Old and new biomarkers and their impact on cardiovascular prognosis Revascularisation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Omar El Zouhayri

Pitie Salpetriere APHP University Hospital, Paris (France)

7 More presentations in this session

Presentation thumbnail
Residual atherosclerotic risk in older patients with ASCVD: where hsCRP meets Lp(a)
Doctor H. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Deciphering diagnostic markers and immune infiltration in ischemic cardiomyopathy: insights from cuproptosis-related genes via bioinformatics and experimental approaches
Doctor X. Tan (Suzhou, CN)
Abstract Slides Video
Presentation thumbnail
Metabolomic profiling of coronary and radial artery samples identifies biomarkers and diagnostic models for coronary microvascular dysfunction
Doctor Q. Su (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Circulating microRNA signatures are associated with epicardial coronary dysfunction in patients underwent invasive physiological evaluation: The ANFIBIO Study
Doctor L. Matute Blanco (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Impact of impaired glucose metabolism on coronary atherosclerosis in patients with very low LDL cholesterol: a potential framework to understand residual risk in chronic coronary syndromes.
Doctor D. Neglia (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Old and new biomarkers and their impact on cardiovascular prognosis

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of cardiac troponin assays reveals assay-specific sensitivities in a clinical model of very acute myocardial injury
thumbnail
Congress Presentation
Imprecision and real-time clinical performance of a whole blood high sensitivity point of care troponin i: ready for prime time?
thumbnail
Congress Presentation
A novel point-of-care high-sensitivity cardiac troponin I assay shows comparable analytical performance and troponin concentrations across sample types in analysis performed by nurses

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources